Microbiology Department, University of Puerto Rico Medical Sciences Campus, San Juan 00936, Puerto Rico.
Int J Mol Sci. 2024 Sep 8;25(17):9715. doi: 10.3390/ijms25179715.
The gut microbiota is one of the most critical factors in human health. It involves numerous physiological processes impacting host health, mainly via immune system modulation. A balanced microbiome contributes to the gut's barrier function, preventing the invasion of pathogens and maintaining the integrity of the gut lining. Dysbiosis, or an imbalance in the gut microbiome's composition and function, disrupts essential processes and contributes to various diseases. This narrative review summarizes key findings related to the gut microbiota in modern multifactorial inflammatory conditions such as ulcerative colitis or Crohn's disease. It addresses the challenges posed by antibiotic-driven dysbiosis, particularly in the context of infections, and the development of novel therapies like fecal microbiota transplantation and biotherapeutic drugs to combat these infections. An emphasis is given to restoration of the healthy gut microbiome through dietary interventions, probiotics, prebiotics, and novel approaches for managing gut-related diseases.
肠道微生物群是人类健康的最重要因素之一。它涉及到许多生理过程,影响着宿主的健康,主要是通过免疫系统的调节。一个平衡的微生物群有助于维持肠道的屏障功能,防止病原体的入侵,并保持肠道内壁的完整性。肠道微生物群的组成和功能失调,或失衡,会破坏重要的过程,并导致各种疾病。本综述总结了与溃疡性结肠炎或克罗恩病等现代多因素炎症性疾病相关的肠道微生物群的关键发现。它解决了抗生素驱动的微生物失调带来的挑战,特别是在感染的情况下,以及粪便微生物群移植和生物治疗药物等新型疗法的发展,以对抗这些感染。通过饮食干预、益生菌、益生元以及管理肠道相关疾病的新方法来恢复健康的肠道微生物群是重点。